摘要 |
Method for indentifying a compound useful for the therapeutic treatment of a neurological disease or disorder such as stroke, head trauma, spinal cord injury, epilepsy, anxiety, or neurodegenerative diseases such as Alzheimer's Disease, Huntington's Disease or Parkinson's Disease, or useful as a muscle relaxant, analgesic, or adjuvant to general anesthetics. The compounds is active on a receptor-operated calcium channel, including, but not limited to, that present as part of an NMDA receptor-ionophore complex, a calcium-permeable AMPA receptor, or a nicotinic cholinergic receptor, as a noncompetitive antagonist. The method includes identifying a compound which binds to the receptor-operated calcium channel at the site bound by the arylalkylamines Compound 1, Compound 2 or Compound 3. |
申请人 |
NPS PHARMACEUTICALS, INC.;MUELLER, ALAN, L.;VAN WAGENEN, BRADFORD, C.;DELMAR, ERIC, G.;BALANDRIN, MANUEL, F.;MOE, SCOTT, T.;ARTMAN, LINDA, D. |
发明人 |
MUELLER, ALAN, L.;VAN WAGENEN, BRADFORD, C.;DELMAR, ERIC, G.;BALANDRIN, MANUEL, F.;MOE, SCOTT, T.;ARTMAN, LINDA, D. |